Short answer
Alkermes plc. (ALKS) filed an 8-K current report with the SEC on July 8, 2026 reporting Item 1.02 (Termination of a Material Definitive Agreement). Amneal terminated the VIVITROL authorized-generic supply agreement effective July 6, 2026.
Alkermes plc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.02 · Termination of a Material Definitive Agreement
- Amneal terminated the VIVITROL authorized-generic supply agreement effective July 6, 2026
- Amneal will not order product batches, eliminating expected authorized-generic sales and profit-sharing opportunities
- Alkermes incurred no termination penalties and has no remaining payment or performance obligations
- Mutual releases eliminate future claims related to the agreement for both parties and affiliates
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Alkermes plc. 8-K filings
Get the next ALKS 8-K as it lands
Follow ALKS for push alerts, or ask the research agent what this filing means.